Live Micron Technology Inc Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about

Most recent public disclosures: AI-powered summaries of the latest corporate filings

25501
1
Senseonics Holdings, Inc. Senseonics Reports $78.6 Million Net Loss for 2024, Despite Slight Revenue Increase

Via official filing (AI summary) | over 1 year ago | 0 comments

25502
1
PLIANT THERAPEUTICS, INC. Pliant Therapeutics Reports $210.3 Million Net Loss and Nil Revenue for 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

25503
1
Fractyl Health, Inc. Fractyl Health Reports $68.7M Net Loss in 2024, Announces Strategic Reprioritization

Via official filing (AI summary) | over 1 year ago | 0 comments

25504
1
ACM Research, Inc. ACM Research Reports 40.2% Revenue Increase to $782.1 Million for Fiscal Year 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

25505
1
BIODESIX INC Biodesix Reports 45% Revenue Growth to $71.3 Million for 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

25506
1
WESBANCO INC Wesbanco Reports $141.4 Million Net Income for 2024, Completes Premier Financial Acquisition

Via official filing (AI summary) | over 1 year ago | 0 comments

25507
1
Sunnova Energy International Inc. Sunnova Energy Reports $367.9 Million Net Loss and 17% Revenue Growth for 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

25508
1
TG THERAPEUTICS, INC. TG Therapeutics Reports $23.38 Million Net Income for Fiscal Year 2024, Driven by BRIUMVI Revenue Growth

Via official filing (AI summary) | over 1 year ago | 0 comments

25509
1
MeiraGTx Holdings plc MeiraGTx Reports $147.8 Million Net Loss for 2024, Highlights Clinical Advancements and Strategic Collaborations

Via official filing (AI summary) | over 1 year ago | 0 comments

25510
1
NEWMARK GROUP, INC. Newmark Group Reports $2.7 Billion Revenue for Fiscal Year 2024, Driven by Growth in All Revenue Streams

Via official filing (AI summary) | over 1 year ago | 0 comments

25511
1
SOUTHERN COPPER CORP/ Southern Copper Corporation Reports Record Net Sales of $11.4 Billion for 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

25512
1
Hilton Grand Vacations Inc. Hilton Grand Vacations Reports $4.98 Billion Revenue, $47 Million Net Income for 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

25513
1
OPKO HEALTH, INC. OPKO Health Reports $152.1 Million Loss and 17% Revenue Decline for 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

25514
1
Mersana Therapeutics, Inc. Mersana Therapeutics Reports $69.2 Million Net Loss for 2024, Collaboration Revenue Increases

Via official filing (AI summary) | over 1 year ago | 0 comments

25515
1
PMV Pharmaceuticals, Inc. PMV Pharmaceuticals Reports $58.7 Million Net Loss for 2024, Advances Rezatapopt in Clinical Trials

Via official filing (AI summary) | over 1 year ago | 0 comments

25516
1
Edgewise Therapeutics, Inc. Edgewise Therapeutics Reports $133.8 Million Net Loss for 2024, Driven by Increased Operating Expenses

Via official filing (AI summary) | over 1 year ago | 0 comments

25517
1
CLOVER HEALTH INVESTMENTS, CORP. /DE Clover Health Reports $46.3 Million Net Loss for 2024, Revenue Increases to $1.37 Billion

Via official filing (AI summary) | over 1 year ago | 0 comments

25518
1
ImmunityBio, Inc. ImmunityBio Reports $413.6 Million Net Loss for 2024, Significant Revenue Growth from ANKTIVA

Via official filing (AI summary) | over 1 year ago | 0 comments

25519
1
Repare Therapeutics Inc. Repare Therapeutics Reports $84.7 Million Net Loss for 2024, Revenue Increases to $53.5 Million

Via official filing (AI summary) | over 1 year ago | 0 comments

25520
1
ArriVent Biopharma, Inc. ArriVent Biopharma Reports $80.5 Million Net Loss for 2024, Increases R&D Spending

Via official filing (AI summary) | over 1 year ago | 0 comments

25521
1
OCULAR THERAPEUTIX, INC Ocular Therapeutix Reports $193.5 Million Net Loss for 2024, Increases DEXTENZA Sales by 9.7%

Via official filing (AI summary) | over 1 year ago | 0 comments

25522
1
Hut 8 Corp. Hut 8 Corp. Reports $162.4 Million Revenue and $331.9 Million Net Income for 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

25523
1
Apogee Therapeutics, Inc. Apogee Therapeutics Reports $182.1 Million Net Loss for Year Ended December 31, 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

25524
1
REDWOOD TRUST INC Redwood Trust Reports $54M Net Income for 2024, Significant Revenue Increases

Via official filing (AI summary) | over 1 year ago | 0 comments

25525
1
Atea Pharmaceuticals, Inc. Atea Pharmaceuticals Reports $168.4 Million Net Loss for 2024, Plans Phase 3 Trials for HCV Treatment

Via official filing (AI summary) | over 1 year ago | 0 comments